FDA and PATH Malaria Vaccine Initiative Announce Research Collaboration The
FDA and PATH Malaria Vaccine Initiative Announce Research Collaboration
The U.S. Food and Drug Administration has announced a collaboration with the PATH Malaria Vaccine Initiative (PATH-MVI) to develop laboratory tests to better predict the level of safety and effectiveness of experimental malaria vaccines before they are used in human clinical trials.